Eiffage SA
XBER:EF3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eiffage SA
XBER:EF3
|
FR |
|
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
|
ID |
|
NextDecade Corp
NASDAQ:NEXT
|
US |
|
Calumet Specialty Products Partners LP
NASDAQ:CLMT
|
US |
|
G2 Goldfields Inc
XTSX:GTWO
|
CA |
|
Plenti Group Ltd
ASX:PLT
|
AU |
|
C
|
Cypher Metaverse Inc
CNSX:CODE
|
CA |
|
S
|
SEI Medical PCL
SET:SEI
|
TH |
|
DS Smith PLC
LSE:SMDS
|
UK |
|
C
|
Company K Partners Ltd
KOSDAQ:307930
|
KR |
Wall Street
Price Targets
EF3 Price Targets Summary
Eiffage SA
According to Wall Street analysts, the average 1-year price target for
EF3
is 142.53 EUR
with a low forecast of 113.72 EUR and a high forecast of 168.36 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EF3's stock price target?
Price Target
142.53
EUR
According to Wall Street analysts, the average 1-year price target for
EF3
is 142.53 EUR
with a low forecast of 113.72 EUR and a high forecast of 168.36 EUR.
What is Eiffage SA's Revenue forecast?
Projected CAGR
4%
For the last 13 years the
compound annual growth rate for
Eiffage SA's revenue is
4%.
The projected
CAGR
for the next 4 years is
4%.
What is Eiffage SA's Operating Income forecast?
Projected CAGR
5%
For the last 13 years the
compound annual growth rate for
Eiffage SA's operating income is
7%.
The projected
CAGR
for the next 4 years is
5%.
What is Eiffage SA's Net Income forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Eiffage SA's net income is
13%.
The projected
CAGR
for the next 4 years is
7%.